1229.1000 19.50 (1.61%)
NSE Apr 30, 2025 15:31 PM
Volume: 1.1M
 

1229.10
1.61%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Please refer to our letter dated May 26, 2022 wherein we have intimated the schedule of Investors/ Analysts call on May 31, 2022. In this connection, we enclose herewith the presentation that would be used in the Investors / Analysts call on the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2022. The presentation is also being uploaded in the following weblink of the Company. https://www.aurobindo.com/investors/results-reports-presentations/results-announcements/
More from Aurobindo Pharma …
All earning calls
Investor presentations from Aurobindo Pharma …
All investor presentations